<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:VCYT (USA) Also Trade In: Germany

Veracyte Inc $ 24.67 -0.65 (-2.57%)

Volume:
450,600
Avg Vol (1m):
623,040
Market Cap $:
1.20 Bil
Enterprise Value $:
1.02 Bil
P/E (TTM):
0.00
P/B:
4.50
Warning! GuruFocus has detected 1 Severe warning sign with VCYT. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for VCYT (Veracyte) from 2013 to Oct 20 2019. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Veracyte stock (VCYT) PE ratio as of Oct 20 2019 is 0. More Details

Veracyte PE Ratio (TTM) Chart

EMBED

Veracyte PE Ratio (TTM) Historical Data

Total 1251
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Veracyte PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2019-10-200.0 2019-08-190.0
2019-10-180.0 2019-08-160.0
2019-10-170.0 2019-08-150.0
2019-10-160.0 2019-08-140.0
2019-10-150.0 2019-08-130.0
2019-10-140.0 2019-08-120.0
2019-10-110.0 2019-08-090.0
2019-10-100.0 2019-08-080.0
2019-10-090.0 2019-08-070.0
2019-10-080.0 2019-08-060.0
2019-10-070.0 2019-08-050.0
2019-10-040.0 2019-08-020.0
2019-10-030.0 2019-08-010.0
2019-10-020.0 2019-07-310.0
2019-10-010.0 2019-07-300.0
2019-09-300.0 2019-07-290.0
2019-09-270.0 2019-07-260.0
2019-09-260.0 2019-07-250.0
2019-09-250.0 2019-07-240.0
2019-09-240.0 2019-07-230.0
2019-09-230.0 2019-07-220.0
2019-09-200.0 2019-07-190.0
2019-09-190.0 2019-07-180.0
2019-09-180.0 2019-07-170.0
2019-09-170.0 2019-07-160.0
2019-09-160.0 2019-07-150.0
2019-09-130.0 2019-07-120.0
2019-09-120.0 2019-07-110.0
2019-09-110.0 2019-07-100.0
2019-09-100.0 2019-07-090.0
2019-09-090.0 2019-07-080.0
2019-09-060.0 2019-07-050.0
2019-09-050.0 2019-07-040.0
2019-09-040.0 2019-07-030.0
2019-09-030.0 2019-07-020.0
2019-09-020.0 2019-07-010.0
2019-08-300.0 2019-06-280.0
2019-08-290.0 2019-06-270.0
2019-08-280.0 2019-06-260.0
2019-08-270.0 2019-06-250.0
2019-08-260.0 2019-06-240.0
2019-08-230.0 2019-06-210.0
2019-08-220.0 2019-06-200.0
2019-08-210.0 2019-06-190.0
2019-08-200.0 2019-06-180.0

Veracyte PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Biotechnology » Biotechnology NAICS : 325412 NAICS : 2834
Traded in other countries 12V.Germany VCYT.USA
Address 6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against the diseases such as thyroid cancer, lung cancer etc. The firm's product portfolio consists of products such as Afirma analysis, Percepta classifier and Envisia classifier. It also has products pipeline such as Enhanced afirma GEC and Expanded indications for the Percepta classifier. The company derives its revenues from the Sale of Afirma analysis product.